Poseida Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two
Poseida Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid, Year Two of $5.11 million as of 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo · last filed 2024-11-07
- 2024-09-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $5.11M.
- 2024-06-30: Lessee, Operating Lease, Liability, to be Paid, Year Two $5.11M.
- 2024-03-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $5.11M.
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, Year Two $6.37M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year Two |
|---|---|
| 2024-09-30 | $5.11M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $5.11M 10-Q · filed 2024-08-05 |
| 2024-03-31 | $5.11M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $6.37M 10-K · filed 2024-03-07 |
| 2023-09-30 | $6.37M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $6.37M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $6.37M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.19M 10-K · filed 2023-03-09 |
| 2022-09-30 | $6.19M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $6.19M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $6.19M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $5.72M 10-K · filed 2022-03-10 |
| 2021-09-30 | $5.55M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.55M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $5.55M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $4.33M 10-K · filed 2021-03-11 |
| 2020-09-30 | $4.30M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $3.50M 10-Q · filed 2020-08-20 |